{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:00:19Z","timestamp":1784300419501,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1245\/s10434-025-18570-5","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:42:53Z","timestamp":1761054173000},"page":"1460-1469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30\/PRODIGE 53 (NCT03164655)"],"prefix":"10.1245","volume":"33","author":[{"given":"Alice","family":"Boil\u00e8ve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Audemar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dupont-Bierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Le Sourd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Ulusakarya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Chauvenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmahame","family":"Benmaziame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Goere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Dromain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Gelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Pezzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Tanguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Boige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"18570_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","volume":"244","author":"S Manfredi","year":"2006","unstructured":"Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier A-M. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254\u20139. https:\/\/doi.org\/10.1097\/01.sla.0000217629.94941.cf.","journal-title":"Ann Surg."},{"key":"18570_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/bjs.5278","volume":"93","author":"J Leporrier","year":"2006","unstructured":"Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006;93:465\u201374. https:\/\/doi.org\/10.1002\/bjs.5278.","journal-title":"Br J Surg."},{"key":"18570_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/cncr.22448","volume":"109","author":"LC Cummings","year":"2007","unstructured":"Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109:718\u201326. https:\/\/doi.org\/10.1002\/cncr.22448.","journal-title":"Cancer."},{"key":"18570_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/path.1711500308","volume":"150","author":"L Weiss","year":"1986","unstructured":"Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986;150:195\u2013203. https:\/\/doi.org\/10.1002\/path.1711500308.","journal-title":"J Pathol."},{"key":"18570_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/bjs.1800771115","volume":"77","author":"J Scheele","year":"1990","unstructured":"Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241\u20136. https:\/\/doi.org\/10.1002\/bjs.1800771115.","journal-title":"Br J Surg."},{"key":"18570_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","volume":"235","author":"MA Choti","year":"2002","unstructured":"Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759\u201366. https:\/\/doi.org\/10.1097\/00000658-200206000-00002.","journal-title":"Ann Surg."},{"key":"18570_CR7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/sj.bjc.6603033","volume":"94","author":"PC Simmonds","year":"2006","unstructured":"Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982\u201399. https:\/\/doi.org\/10.1038\/sj.bjc.6603033.","journal-title":"Br J Cancer."},{"key":"18570_CR8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","volume":"240","author":"R Adam","year":"2004","unstructured":"Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644\u201357. https:\/\/doi.org\/10.1097\/01.sla.0000141198.92114.f6.","journal-title":"Ann Surg."},{"key":"18570_CR9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.ejca.2014.02.024","volume":"50","author":"RP Jones","year":"2014","unstructured":"Jones RP, Hamann S, Malik HZ, Fenwick SW, Poston GJ, Folprecht G. Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer. Eur J Cancer. 2014;50:1590\u2013601. https:\/\/doi.org\/10.1016\/j.ejca.2014.02.024.","journal-title":"Eur J Cancer."},{"key":"18570_CR10","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1200\/JCO.2007.10.8126","volume":"25","author":"R Adam","year":"2007","unstructured":"Adam R, Aloia T, L\u00e9vi F, Wicherts DA, de Haas RJ, Paule B, et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol. 2007;25:4593\u2013602. https:\/\/doi.org\/10.1200\/JCO.2007.10.8126.","journal-title":"J Clin Oncol."},{"key":"18570_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/annonc\/mdu580","volume":"26","author":"T Gruenberger","year":"2015","unstructured":"Gruenberger T, Bridgewater J, Chau I, Garc\u00eda Alfonso P, Rivoire M, Mudan S, et al. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. Ann Oncol. 2015;26:702\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdu580.","journal-title":"Ann Oncol."},{"key":"18570_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1200\/JCO.2012.44.8308","volume":"31","author":"L-C Ye","year":"2013","unstructured":"Ye L-C, Liu T-S, Ren L, Wei Y, Zhu D-X, Zai S-Y, et al. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol. 2013;31:1931\u20138. https:\/\/doi.org\/10.1200\/JCO.2012.44.8308.","journal-title":"J Clin Oncol."},{"key":"18570_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","volume":"206","author":"AE Chang","year":"1987","unstructured":"Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987;206:685\u201393.","journal-title":"Ann Surg."},{"key":"18570_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","volume":"107","author":"N Kemeny","year":"1987","unstructured":"Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial Ann Intern Med. 1987;107:459\u201365. https:\/\/doi.org\/10.7326\/0003-4819-107-4-459.","journal-title":"A randomized trial. Ann Intern Med."},{"key":"18570_CR15","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","volume":"7","author":"DC Hohn","year":"1989","unstructured":"Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989;7:1646\u201354. https:\/\/doi.org\/10.1200\/JCO.1989.7.11.1646.","journal-title":"J Clin Oncol."},{"key":"18570_CR16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/archsurg.1990.01410200086013","volume":"125","author":"JK Martin","year":"1990","unstructured":"Martin JK, O\u2019Connell MJ, Wieand HS, Fitzgibbons RJ, Mailliard JA, Rubin J, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial Arch Surg. 1990;125:1022\u20137. https:\/\/doi.org\/10.1001\/archsurg.1990.01410200086013.","journal-title":"A randomized trial. Arch Surg."},{"key":"18570_CR17","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","volume":"10","author":"P Rougier","year":"1992","unstructured":"Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992;10:1112\u20138. https:\/\/doi.org\/10.1200\/JCO.1992.10.7.1112.","journal-title":"J Clin Oncol."},{"key":"18570_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/s0140-6736(94)90750-1","volume":"344","author":"TG Allen-Mersh","year":"1994","unstructured":"Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994;344:1255\u201360. https:\/\/doi.org\/10.1016\/s0140-6736(94)90750-1.","journal-title":"Lancet."},{"key":"18570_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1200\/JCO.2000.18.2.243","volume":"18","author":"M Lorenz","year":"2000","unstructured":"Lorenz M, M\u00fcller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2000;18:243\u201354. https:\/\/doi.org\/10.1200\/JCO.2000.18.2.243.","journal-title":"J Clin Oncol."},{"key":"18570_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(03)12388-4","volume":"361","author":"DJ Kerr","year":"2003","unstructured":"Kerr DJ, McArdle CS, Ledermann J, Taylor I, Sherlock DJ, Schlag PM, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet. 2003;361:368\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(03)12388-4.","journal-title":"Lancet."},{"key":"18570_CR21","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","volume":"24","author":"NE Kemeny","year":"2006","unstructured":"Kemeny NE, Niedzwiecki D, Hollis DR, Lenz H-J, Warren RS, Naughton MJ, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006;24:1395\u2013403. https:\/\/doi.org\/10.1200\/JCO.2005.03.8166.","journal-title":"J Clin Oncol."},{"key":"18570_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007823.pub2","author":"S Mocellin","year":"2009","unstructured":"Mocellin S, Pasquali S, Nitti D. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2009. https:\/\/doi.org\/10.1002\/14651858.CD007823.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"18570_CR23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/jso.21753","volume":"102","author":"TP Kingham","year":"2010","unstructured":"Kingham TP, D\u2019Angelica M, Kemeny NE. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases. J Surg Oncol. 2010;102:988\u201395. https:\/\/doi.org\/10.1002\/jso.21753.","journal-title":"J Surg Oncol."},{"key":"18570_CR24","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1200\/JCO.2008.20.1301","volume":"27","author":"NE Kemeny","year":"2009","unstructured":"Kemeny NE, Melendez FDH, Capanu M, Paty PB, Fong Y, Schwartz LH, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009;27:3465\u201371. https:\/\/doi.org\/10.1200\/JCO.2008.20.1301.","journal-title":"J Clin Oncol."},{"key":"18570_CR25","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","volume":"23","author":"M Ducreux","year":"2005","unstructured":"Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol. 2005;23:4881\u20137. https:\/\/doi.org\/10.1200\/JCO.2005.05.120.","journal-title":"J Clin Oncol."},{"key":"18570_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/SLA.0b013e3181d35983","volume":"251","author":"D Go\u00e9r\u00e9","year":"2010","unstructured":"Go\u00e9r\u00e9 D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, et al. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg. 2010;251:686\u201391. https:\/\/doi.org\/10.1097\/SLA.0b013e3181d35983.","journal-title":"Ann Surg."},{"key":"18570_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1245\/s10434-007-9581-7","volume":"15","author":"V Boige","year":"2008","unstructured":"Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, et al. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol. 2008;15:219\u201326. https:\/\/doi.org\/10.1245\/s10434-007-9581-7.","journal-title":"Ann Surg Oncol."},{"key":"18570_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12885-020-6571-7","volume":"20","author":"A Boil\u00e8ve","year":"2020","unstructured":"Boil\u00e8ve A, Maillard A, Wagner M, Dromain C, Laurent C, Bierre ED, et al. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study \u2013 SULTAN UCGI 30\/PRODIGE 53 (NCT03164655)- study protocol. BMC Cancer. 2020;20:74. https:\/\/doi.org\/10.1186\/s12885-020-6571-7.","journal-title":"BMC Cancer."},{"key":"18570_CR29","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1634\/theoncologist.2012-0121","volume":"17","author":"R Adam","year":"2012","unstructured":"Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225\u201339. https:\/\/doi.org\/10.1634\/theoncologist.2012-0121.","journal-title":"Oncologist."},{"key":"18570_CR30","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/annonc\/mdu260","volume":"25 Suppl","author":"E Van Cutsem","year":"2014","unstructured":"Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. ESMO Guidelines Working Group. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl:iii1-9. https:\/\/doi.org\/10.1093\/annonc\/mdu260.","journal-title":"Ann Oncol."},{"key":"18570_CR31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.dld.2019.05.035","volume":"51","author":"JM Phelip","year":"2019","unstructured":"Phelip JM, Tougeron D, L\u00e9onard D, Benhaim L, Desolneux G, Dupr\u00e9 A, et al. Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis. 2019;51:1357\u201363. https:\/\/doi.org\/10.1016\/j.dld.2019.05.035.","journal-title":"Dig Liver Dis."},{"key":"18570_CR32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00270-010-9996-6","volume":"34","author":"F Deschamps","year":"2011","unstructured":"Deschamps F, Elias D, Goere D, Malka D, Ducreux M, Boige V, et al. Intra-arterial hepatic chemotherapy: a comparison of percutaneous versus surgical implantation of port-catheters. Cardiovasc Intervent Radiol. 2011;34:973\u20139. https:\/\/doi.org\/10.1007\/s00270-010-9996-6.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"18570_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer."},{"key":"18570_CR34","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouch\u00e9 O, Guimbaud R, B\u00e9couarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1011923.","journal-title":"N Engl J Med."},{"key":"18570_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.seminoncol.2010.03.003","volume":"37","author":"JB Ammori","year":"2010","unstructured":"Ammori JB, Kemeny NE. Regional hepatic chemotherapies in treatment of colorectal cancer metastases to the liver. Semin Oncol. 2010;37:139\u201348. https:\/\/doi.org\/10.1053\/j.seminoncol.2010.03.003.","journal-title":"Semin Oncol."},{"key":"18570_CR36","doi-asserted-by":"publisher","unstructured":"Levi F, Ducreux M, Smith DM, Hebbar M, Lep\u00e8re C, Focan CNJ, et al. Four-year survival in patients (pts) undergoing liver surgery after neoadjuvant triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) for previously treated and unresectable liver metastases from kras wt colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228). Journal of Clinical Oncology. 2014;32 15_suppl:3589\u20133589. https:\/\/doi.org\/10.1200\/jco.2014.32.15_suppl.3589.","DOI":"10.1200\/jco.2014.32.15_suppl.3589"},{"key":"18570_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/1097-0142(19920115)69:2<327::aid-cncr2820690209>3.0.co;2-u","volume":"69","author":"N Kemeny","year":"1992","unstructured":"Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer. 1992;69:327\u201334. https:\/\/doi.org\/10.1002\/1097-0142(19920115)69:2%3c327::aid-cncr2820690209%3e3.0.co;2-u.","journal-title":"Cancer."},{"key":"18570_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejca.2020.07.022","volume":"138","author":"A Boil\u00e8ve","year":"2020","unstructured":"Boil\u00e8ve A, De Cuyper A, Larive A, Mahjoubi L, Najdawi M, Tazdait M, et al. Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases. Eur J Cancer. 2020;138:89\u201398. https:\/\/doi.org\/10.1016\/j.ejca.2020.07.022.","journal-title":"Eur J Cancer."},{"key":"18570_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-10887-1","author":"L Meyblum","year":"2024","unstructured":"Meyblum L, Faron M, Deschamps F, Kobe A, Bonnet B, Boileve A, et al. Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion Chemotherapy. Eur Radiol. 2024. https:\/\/doi.org\/10.1007\/s00330-024-10887-1.","journal-title":"Eur Radiol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18570-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18570-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18570-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:33:58Z","timestamp":1767573238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18570-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18570"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18570-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received the ethical approval of the Comit\u00e9 de Protection des Personnes \u2013 Ile de France V. N\u00b0 EudraCT: 2016-001493-15 (Date of approval October 13, 2017).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"This study does not contain individual data of patients in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}